AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following third quarter results for the period ended September 30,
Joint system-level testing combines Stevanato Group glass syringes with Aptar Pharma elastomer components to provide key data earlier in development and help inform packaging decisions for sensitive biologics and other
Acquisition is expected to accelerate development and commercialization of Kolibri™ and expand Aptar Pharma’s respiratory drug delivery platform
Aptar Pharma, a global leader in drug delivery, dosing, protection
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced the appointment of Virginie Maes as President of Aptar Pharma,
Milestone strengthens Aptar Pharma’s support for intranasal vaccine development from clinical studies through commercialization
Aptar Pharma, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery,
Goal is to help pharmaceutical innovators evaluate opportunities earlier and accelerate future central nervous system pipelines
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results for the period ended June 30,
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the World’s Most Sustainable Companies
Dermalogica Selects Innovative Technology for its FutureCode Skincare Booster
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing,
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share.
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the America’s Best Companies 2026 by
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2025 Corporate Sustainability Report entitled Progress in Motion. The report
Recognized for Continued Supply Chain Collaboration
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, was named a CDP Supplier
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it will present at two upcoming investor conferences:
Jefferies
Innovation wins 2026 DIELINE Award with Clarins Total Eye Lift for ‘Sustainable Design – Health, Body & Beauty'
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies,
